A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer

NCT00600535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Neoplasms

Interventions

DRUG: Stage 1 Group 1: abiraterone acetate
DRUG: Stage 1 Group 2: abiraterone acetate
DRUG: Stage 2: abiraterone acetate
DRUG: Stage 3: abiraterone acetate
DRUG: Stage 3: glucocorticoid
DRUG: Stage 4: abiraterone acetate
DRUG: Stage 4: glucocorticoid

Sponsor

Cougar Biotechnology, Inc.